Sotera Health Co (SHC)
11.30
-0.12
(-1.01%)
USD |
NASDAQ |
May 17, 16:00
11.30
0.00 (0.00%)
After-Hours: 20:00
Sotera Health Enterprise Value: 5.164B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 5.164B |
| May 16, 2024 | 5.198B |
| May 15, 2024 | 5.198B |
| May 14, 2024 | 5.195B |
| May 13, 2024 | 5.190B |
| May 10, 2024 | 5.093B |
| May 09, 2024 | 5.175B |
| May 08, 2024 | 5.143B |
| May 07, 2024 | 5.215B |
| May 06, 2024 | 5.164B |
| May 03, 2024 | 5.088B |
| May 02, 2024 | 5.057B |
| May 01, 2024 | 5.158B |
| April 30, 2024 | 5.139B |
| April 29, 2024 | 5.190B |
| April 26, 2024 | 5.195B |
| April 25, 2024 | 5.173B |
| April 24, 2024 | 5.158B |
| April 23, 2024 | 5.190B |
| April 22, 2024 | 5.108B |
| April 19, 2024 | 5.068B |
| April 18, 2024 | 5.054B |
| April 17, 2024 | 5.011B |
| April 16, 2024 | 5.051B |
| April 15, 2024 | 5.085B |
| Date | Value |
|---|---|
| April 12, 2024 | 5.161B |
| April 11, 2024 | 5.201B |
| April 10, 2024 | 5.201B |
| April 09, 2024 | 5.258B |
| April 08, 2024 | 5.195B |
| April 05, 2024 | 5.178B |
| April 04, 2024 | 5.195B |
| April 03, 2024 | 5.235B |
| April 02, 2024 | 5.190B |
| April 01, 2024 | 5.280B |
| March 31, 2024 | 5.368B |
| March 28, 2024 | 5.332B |
| March 27, 2024 | 5.289B |
| March 26, 2024 | 5.193B |
| March 25, 2024 | 5.255B |
| March 22, 2024 | 5.128B |
| March 21, 2024 | 5.196B |
| March 20, 2024 | 5.264B |
| March 19, 2024 | 5.640B |
| March 18, 2024 | 5.985B |
| March 15, 2024 | 6.039B |
| March 14, 2024 | 5.943B |
| March 13, 2024 | 5.875B |
| March 12, 2024 | 5.827B |
| March 11, 2024 | 5.892B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.261B
Minimum
Nov 17 2022
10.57B
Maximum
Dec 02 2020
7.037B
Average
7.004B
Median
Jul 28 2022
Enterprise Value Benchmarks
| Fonar Corp | 33.73M |
| XWELL Inc | -7.802M |
| ProPhase Labs Inc | 107.41M |
| Applied DNA Sciences Inc | -0.8053M |
| Veracyte Inc | 1.540B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.323M |
| Revenue (Quarterly) | 248.18M |
| Total Expenses (Quarterly) | 195.00M |
| EPS Diluted (Quarterly) | 0.02 |
| Gross Profit Margin (Quarterly) | 51.22% |
| Profit Margin (Quarterly) | 2.55% |
| Earnings Yield | 1.68% |
| Operating Earnings Yield | 9.28% |
| Normalized Earnings Yield | 2.537 |